DLA Piper advises Sirio Pharma on the acquisition of Ayanda
DLA Piper has advised Sirio Pharma Co., Ltd, one of China's largest healthcare product manufacturers, on the acquisition of Ayanda GmbH & Co. KG, a vitamin and supplement manufacturer, from its holding company Ayanda AS for an undisclosed sum. This was the first investment for Sirio in Europe.